Fasenra Pen 30 mg

Fasenra Pen 30 mg is a subcutaneous solution containing benralizumab, used for managing asthma symptoms. This medication is designed to help control asthma and improve breathing.

Fasenra Pen 30 mg is primarily used for the maintenance treatment of severe eosinophilic asthma in adults and adolescents. Benralizumab, the active ingredient, targets specific cells involved in asthma inflammation. Patients often wonder, 'What is Fasenra Pen used for?' It is typically prescribed for those who have not responded well to other asthma treatments.

Common effects of Fasenra Pen 30 mg may include reactions at the injection site, such as redness or itching. Some users might experience headaches or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Fasenra Pen 30 mg should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always check the solution for particles or discoloration before use.

Fasenra Pen 30 mg may interact with other medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.